<DOC>
	<DOCNO>NCT01395784</DOCNO>
	<brief_summary>The ability pioglitazone ( PIO ) alter effect opioids human characterize controlled laboratory setting . Accordingly , propose investigation seek examine effect PIO oxycodone , one commonly use abuse opioid drug U.S. ( Davis et al. , 2003 ) . More specifically , primary aim investigation characterize subjective effect oxycodone maintenance various dos PIO ( 0 , 15 , 45 mg ) non-dependent , prescription opioid abuser . Secondary aim study examine influence PIO analgesic , cognitive , physiological effect oxycodone .</brief_summary>
	<brief_title>Effects Pioglitazone , PPARgamma Receptor Agonist , Abuse Liability Oxycodone</brief_title>
	<detailed_description>This 9-week investigation use inpatient/outpatient design participant maintain ascend dos pioglitazone ( 3 week placebo follow 3 week PIO 15 mg follow 3 week PIO 45 mg ) . At end maintenance period effect oxycodone ( 0 , 10 , 20 mg ) examine single laboratory session use cumulative dosing procedure .</detailed_description>
	<mesh_term>Pioglitazone</mesh_term>
	<mesh_term>Oxycodone</mesh_term>
	<criteria>1 . Recreational use prescription opioids least per month within past year 2 . No current major mood , psychotic , anxiety disorder 3 . Physically healthy 4. aspartate aminotransferase ( AST ) alanine aminotransferase ( ALT ) within normal limit 5 . Able perform study procedures 6.2145 year age 7.Blood glucose concentration 70145 mg/dl men 70125 mg/dl woman ( fast ) 8.Hb &gt; 13 men Hb &gt; 11 woman evidence medical disorder result blood loss anemia/hematological disease 1 . Physical dependence drug , exclude nicotine caffeine 2 . Participants request treatment 3 . Participants parole probation 4 . Pregnancy lactation : Female participant must agree use barrier control method contraception ( e.g . male female condom , diaphragm , cervical cap contraceptive sponge use combination spermicide ) 5 . Current recent history significant violent behavior ( within past 6 month ) 6 . Current major Axis I psychopathology might interfere ability participate study 7 . Significant suicide risk 8 . Current chronic pain 9 . Current history congestive heart failure , edema , diabetes mellitus 10 . Sensitivity , allergy , contraindication opioids pioglitazone 11 . Unstable physical disorder might make participation hazardous , endstage AIDS , hypertension ( blood pressure &gt; 140/90 ) , heart disease ( please note participant ask previous visit cardiologist , chest pain , strong palpitation ; exist , refer cardiologist exclude unless clear participation cardiologist )</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Oxycodone</keyword>
	<keyword>Opioid abuse</keyword>
</DOC>